CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a technology pipeline for personalized treatment of ovarian cancer. It aims to identify effective drug combinations for patients resistant to standard chemotherapy using high-throughput and microfluidic drug screening techniques.
OvCa for Precision Medicine:
Personalized Ovarian Cancer Treatment using High-Throughput and Microfluidic Drug Screening.
The main issue with current Ovarian Cancer (OvCa) treatments is the eventual resistance to standard platinum-based chemotherapy, which ultimately leads patients to relapse.
Identifying drugs and drug combinations that overcome platinum resistance by new treatment strategies is an unmet medical need in OvCa patients that I plan to address with our technology pipeline as a Proo…
DUBLIN CITY UNIVERSITY
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
